A Pilot Phase II Study Evaluating the Role of Chlorine Dioxide on Mucositis for Patients Undergoing Head and Neck Radiotherapy
This is a Phase 1, single center, prospective, randomized, double-blind, placebo-controlled study assessing the effects of chlorine dioxide oral rinse versus placebo on incidence, time to onset, duration, and patient reported outcomes on radiation therapy related OM, RT interruption, and changes in oral microbiome and cytokine composition.
Study phase: II
Basic eligibility criteria:
Please contact the study coordinator for additional eligibility information.
Patients age 18 or older that will be undergoing radiation therapy or radiation therapy and chemotherapy for the treatment of head and neck cancer
Primary disease category: Cancer
Sponsor: Rowpar Pharmaceuticals, Inc
Projected enrollment dates: April 2017 to April 2019
Official study title: A Pilot Phase II Study Evaluating the Role of Chlorine Dioxide on Mucositis for Patients Undergoing Head and Neck Radiotherapy